Patient Site: VYZULTA® | FDA-Approved Treatment
Sponsored(Latanoprostene Bunod Ophthalmic Solution), 0.024%. Official Patient Website. Savings …Offers And Information · View Copay Offer · Prescribing Information · Sign Up For Updates
CEQUA® cyclosporine | ophthalmic solution 0.09%
SponsoredImpressive efficacy and patient data from former Restasis® users. You have to see results…Preferred By Switchers · CEQUA® Safety · Efficacy Results · Safety & Efficacy

Feedback